Wednesday in The Lancet Microbe.The study focused on infections caused by Aspergillus fumigatus, a fungus that is ubiquitous ...

Every year, life-threatening invasive fungal infections afflict more than 2 million individuals globally. Mortality rates for these infections are high, even when patients receive treatment.

A fungal skin infection happens when a fungus (such as yeast or mold) grows and creates a reaction on your skin surface.

The global candidemia market is poised for strong growth from 2025-2035, fueled by rising candidemia infection rates and a heightened focus on antifungal drug development. Critical drivers include ...

Its potential drug, called SF001, got the nod from the U.S. Food and Drug Administration last year to expedite its development process, as it was designated as a potential antifungal treatment for ...

Antifungal drug developer F2G raises $100 mln to fight 'superbugs', fund late-stage trial. By Kashish Tandon. September 12, 2024 3:00 PM UTC Updated September 12, 2024 U.S ...

A class of antifungal medications called azoles—the first-line treatment for vaginal yeast infections, among other things—are becoming less effective from antifungal drug resistance.

Antifungal drug eliminates sleeping bowel cancer cells in mice. ScienceDaily . Retrieved May 27, 2025 from www.sciencedaily.com / releases / 2018 / 05 / 180531142940.htm ...

Tibsovo (ivosidenib), which is used to treat patients with IDH1-mutant acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) — both of which are types of blood cancer — increases the way that ...

An outbreak of deadly fungal meningitis linked to steroid injections has raised the question of whether people who received the shots, but don't have meningitis symptoms, should take anti-fungal ...